UroGen receives rights to Zalifrelimab for intravesical treatment of urinary tract cancers

In Florida, cancer is part of daily life for thousands of families. It is the state’s second-leading cause of death. Each year, an estimated 115,000 Floridians receive a new cancer diagnosis and certain preventable or virus-linked cancers continue to impose avoidable burdens on communities across the state.